Drugs / NuSepin®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04565379 Comparator | Sep 2020 → Apr 2021 | pneumonia | Shaperon | Completed | No outcome recorded |
| Phase 2/3 | NCT05352347 Comparator | Apr 2022 → Nov 2024 | pneumonia | Shaperon | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NuSepin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04565379 ↗ |
| Route | Intravenous | “NuSepin® intravenous infusion” NCT04565379 ↗ |